Citi downgrades Boston Scientific to Neutral, lowers target price to $50
智通财经2026/09/17 09:46Show original
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold. Trade now!
A welcome pack worth 6200 USDT for new users! Sign up now!
Citi: Downgrades Boston Scientific (BSX.US) from Buy to Neutral; lowers target price from $57 to $50.
0
0
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Coreweave plans to sell up to 35 million Class A common shares
智通财经•2026/09/17 11:31
Coreweave Plans to Issue $3 Billion in Convertible Senior Notes
智通财经•2026/09/17 11:26
